Novel gyrase mutations and characterization of ciprofloxacin-resistant clinical strains of Enterococcus faecalis isolated in Poland

Polish Journal of Microbiology

Volumn 57, Issue 2, 2008, Pages 121-124

  Piekarska, Katarzyna ^a   Gierczyński, Rafał ^a   Ławrynowicz Paciorek, Maja ^a   Kochman, Maria ^a   Jagielski, Marek ^a  

^a NATIONAL INSTITUTE OF HYGIENE   (Poland)

Author keywords

Enterococcus faecalis; Fluoroquinolone resistance; gyrA; parC; QRDR

Indexed keywords

ARGININE; CIPROFLOXACIN; CYSTEINE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE (ATP HYDROLYSING) A; ISOLEUCINE; MOXIFLOXACIN; PROTEIN PARC; SERINE; SPARFLOXACIN; TYROSINE; ANTIINFECTIVE AGENT; BACTERIAL DNA; DNA TOPOISOMERASE IV; HETEROCYCLIC COMPOUND; QUINOLINE DERIVATIVE; QUINOLONE DERIVATIVE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONTROLLED STUDY; DNA SEQUENCE; ENTEROCOCCUS FAECALIS; GENE MUTATION; HOSPITAL PATIENT; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLAND; SEQUENCE ANALYSIS; BACTERIAL GENE; BACTERIAL INFECTION; DRUG EFFECT; GENETICS; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MUTATION; POLYMERASE CHAIN REACTION;

ENTEROCOCCUS FAECALIS;

AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; CIPROFLOXACIN; DNA GYRASE; DNA TOPOISOMERASE IV; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECALIS; FLUOROQUINOLONES; GENES, BACTERIAL; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; POLAND; POLYMERASE CHAIN REACTION; QUINOLINES; SEQUENCE ANALYSIS, DNA;

EID: 48249128438     PISSN: 17331331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Barišić Z. and V. Punda-Polić. 2000. Antibiotic resistance among enterococcal strains isolated from clinical specimens. Internat. J. Antimicrob. Agents 16: 65-68.
2. Clinical Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement M100-S16, vol.26. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, USA.
3. El Amin N., S. Jalal and B. Wretlind. 1999. Alterations in GyrA and ParC associated with fluoroquinolone resistance in Enterococcus faecium. Antimicrob. Agents Chemother. 43: 947-949.
4. Eliopoulos G.M. 1993. Increasing problems in the therapy of enterococcal infections. Eur. J. Clin. Microbiol. Infect. Dis. 6: 409-412.
5. Facklam R. R, D. F. Sahm and L. M. Teixeira. 1999. Manual of Clinical Microbiology, 7th ed. ASM Press, Washington D.C.
6. Gierczyński R., S. Kałuzewski, A. Rakin, M. Jagielski, A. Zasada, A. Jakubezak, B. Borkowska-Opacka and W. Rastawiecki. 2004. Intriguing diversity of Bacillus anthracis in eastern Poland - the molecular echoes of the past outbreaks. FEMS Microbiol. Lett. 239: 235-240.
7. Hunt C.P. 1998. The emergence of enterococci as a cause of nosocomial infection. Br. J. Biomed. Sci. 55: 149-156.
8. Jonas B. M., B. E. Murray and G. M. Weinstock. 2001. Characterization of emeA, a norA homolog and multidrug resistance efflux pump in Enterococcus faecalis. Antimicrob. Agents Chemother. 45: 3574-3579.
9. Kanematsu E., T. Deguchi, M. Yasuda, T. Kawamura, Y. Nishino and Y. Kawada. 1998. Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV associated with quinolone resistance in Enterococcus faecalis. Antimicrob. Agents Chemother. 42: 433-435.
10. Kawalec M., Z. Pietras, E. Daniłowicz, A. Jakubczak, M. Gniadkowski, W. Hryniewicz and R.J.L. Willems. 2007. Clonal structure of Enterococcus faecalis isolated from Polish hospitals: the characterization of epidemic clones. J. Clin. Microbiol. 45: 147-153.
11. Korten V., W.M. Huang and B.E. Murray. 1994. Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluoroquinolone resistance in Enterococcus faecalis. Antimicrob. Agents Chemother. 38: 2091-2094.
12. Onodera Y., J. Okuda, M. Tanaka and K. Sato. 2002. Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV of Enterococcus faecalis. Antimicrob. Agents Chemother. 46: 1800-1804.
13. Oyamada Y., H. Ito, M. Inoue and J. Yamagishi. 2006. Topoisomerase mutations and efflux are associated with fluoroquinolone resistance in Enterococcus faecalis. J. Med. Microbiol. 55: 1395-1401.
14. Schaberg D.R., W.I. Dillon, M.S. Terpenning, K.A. Robinson, S.F. Bradley and C.A. Kauffman. 1992. Increasing resistance of enterococci to ciprofloxacin. Antimicrob. Agents Chemother. 36: 2533-2535.
15. Tankovic J., F. Mahjoubi, P. Courvalin, J. Duval and R. Leclercq. 1996. Development of fluoroquinolone resistance in Enterococcus faecalis and role of mutations in the DNA gyrase gyrA gene. Antimicrob. Agents Chemother. 40: 2558-2561.
16. Zareba T. and W. Hryniewicz. 1995. Patters of antibiotic resistance among enterococcal strains isolated from clinical specimens and food in Poland. Eur. J. Clin. Microbiol. Infect. Dis. 14: 69-71.